{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:59:57Z","timestamp":1793897997235,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejps.2025.107062","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:23:28Z","timestamp":1741609408000},"page":"107062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["DprE1 inhibitors: An insight into the recent developments and synthetic approaches"],"prefix":"10.1016","volume":"209","author":[{"given":"Mai I.","family":"Shahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai A.","family":"Elyamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed E.","family":"Elsawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed T.","family":"Negmeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahenda","family":"Naguib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Safwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6996-4017","authenticated-orcid":false,"given":"Wagdy M.","family":"Eldehna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107062_bib0002","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/13543776.2022.2012151","article-title":"An updated patent review on drugs for the treatment of tuberculosis (2018-present)","volume":"32","author":"Ahmed","year":"2022","journal-title":"Expert. Opin. Ther. Pat."},{"key":"10.1016\/j.ejps.2025.107062_bib0003","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021113","article-title":"The mycobacterial cell wall\u2013peptidoglycan and arabinogalactan","volume":"5","author":"Alderwick","year":"2015","journal-title":"Cold. Spring. Harb. Perspect. Med."},{"key":"10.1016\/j.ejps.2025.107062_bib0004","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1021\/acs.jmedchem.0c00107","article-title":"Optimization of hydantoins as potent antimycobacterial decaprenylphosphoryl-\u03b2-d-ribose oxidase (DprE1) inhibitors","volume":"63","author":"Balabon","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0005","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/cbdd.13747","article-title":"6-Nitro-1-benzylquinolones exhibiting specific antitubercular activity","volume":"96","author":"Beteck","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejps.2025.107062_bib0006","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejmech.2015.04.011","article-title":"Development of selective DprE1 inhibitors: design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides","volume":"96","author":"Chikhale","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0007","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.1021\/acs.jmedchem.8b00281","article-title":"Overview of the development of DprE1 inhibitors for combating the menace of tuberculosis","volume":"61","author":"Chikhale","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000645","article-title":"High content screening identifies decaprenyl-phosphoribose 2\u2032 epimerase as a target for intracellular antimycobacterial inhibitors","volume":"5","author":"Christophe","year":"2009","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.ejps.2025.107062_bib0009","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/app10020623","article-title":"Promiscuous targets for antitubercular drug discovery: the paradigm of DprE1 and MmpL3","volume":"10","author":"Degiacomi","year":"2020","journal-title":"Applied Sciences"},{"key":"10.1016\/j.ejps.2025.107062_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113207","article-title":"Easily accessed nitroquinolones exhibiting potent and selective anti-tubercular activity","volume":"213","author":"Dube","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115539","article-title":"Quinolone analogues of benzothiazinone: synthesis, antitubercular structure-activity relationship and ADME profiling","volume":"258","author":"Dube","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2025.107062_bib0012","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/14756366.2020.1868450","article-title":"Development of novel isatin\u2013nicotinohydrazide hybrids with potent activity against susceptible\/resistant mycobacterium tuberculosis and bronchitis causing\u2013bacteria","volume":"36","author":"Elsayed","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0013","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/biomed4030018","article-title":"Unveiling DprE1 as a key target in the fight against tuberculosis: insights and perspectives on developing novel antimicrobial agents","volume":"4","author":"Fil","year":"2024","journal-title":"BioMed"},{"key":"10.1016\/j.ejps.2025.107062_bib0014","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1055\/s-1987-27834","article-title":"Nickel-catalyzed synthesis of arylacetonitriles from Arylzinc chlorides and bromoacetonitrile","volume":"1987","author":"Frejd","year":"1987","journal-title":"Synthesis. (Mass)"},{"key":"10.1016\/j.ejps.2025.107062_bib0015","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.2174\/0929867324666171009103327","article-title":"Benzothiazole-based compounds in antibacterial drug discovery","volume":"25","author":"Gjorgjieva","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0016","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02020-19","article-title":"OPC-167832, a novel carbostyril derivative with potent antituberculosis activity as a DprE1 inhibitor","volume":"64","author":"Hariguchi","year":"2020","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.ejps.2025.107062_bib0001","unstructured":"https:\/\/www.who.int\/news\/item\/07-11-2023-tuberculosis-response-recovering-from-pandemic-but\u2013accelerated-efforts-needed-to-meet-new-targets, in."},{"key":"10.1016\/j.ejps.2025.107062_bib0017","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jiph.2023.02.005","article-title":"Computer-assisted discovery of safe and effective DprE1\/aaRSs inhibitors against TB utilizing drug repurposing approach","volume":"16","author":"Imran","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.ejps.2025.107062_bib0018","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jiph.2022.08.016","article-title":"An insight into the discovery, clinical studies, compositions, and patents of macozinone: a drug targeting the DprE1 enzyme of mycobacterium tuberculosis","volume":"15","author":"Imran","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.ejps.2025.107062_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107138","article-title":"Identification of new anti-mycobacterial agents based on quinoline-isatin hybrids targeting enoyl acyl carrier protein reductase (InhA)","volume":"144","author":"Khaleel","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0020","doi-asserted-by":"crossref","first-page":"7694","DOI":"10.1016\/j.bmc.2015.11.017","article-title":"Discovery of benzothiazoles as antimycobacterial agents: synthesis, structure-activity relationships and binding studies with mycobacterium tuberculosis decaprenylphosphoryl-\u03b2-D-ribose 2\u2032-oxidase","volume":"23","author":"Landge","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0021","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejmech.2018.09.042","article-title":"Identification of novel benzothiopyranone compounds against mycobacterium tuberculosis through scaffold morphing from benzothiazinones","volume":"160","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0022","doi-asserted-by":"crossref","first-page":"14410","DOI":"10.1039\/D0RA00750A","article-title":"Identification of benzothiazones containing a hexahydropyrrolo[3,4-c]pyrrol moiety as antitubercular agents against MDR-MTB","volume":"10","author":"Ma","year":"2020","journal-title":"RSC. Adv."},{"key":"10.1016\/j.ejps.2025.107062_bib0023","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tube.2010.09.001","article-title":"Leads for antitubercular compounds from kinase inhibitor library screens","volume":"90","author":"Magnet","year":"2010","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejps.2025.107062_bib0024","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.1171583","article-title":"Benzothiazinones kill mycobacterium tuberculosis by blocking arabinan synthesis","volume":"324","author":"Makarov","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejps.2025.107062_bib0025","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1128\/AAC.00778-15","article-title":"The 8-pyrrole-benzothiazinones are noncovalent inhibitors of DprE1 from mycobacterium tuberculosis","volume":"59","author":"Makarov","year":"2015","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.ejps.2025.107062_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5099312","article-title":"Advances in key drug target identification and new drug development for tuberculosis","volume":"2022","author":"Mi","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ejps.2025.107062_bib0027","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1021\/jm5005978","article-title":"4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity","volume":"57","author":"Naik","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0028","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/cb5007163","article-title":"2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1","volume":"10","author":"Neres","year":"2015","journal-title":"ACS. Chem. Biol."},{"key":"10.1016\/j.ejps.2025.107062_bib0029","unstructured":"Z.K. No, J Brodin, P.; Seo, M.J.; Kim, Y.M.; Cechetto, J.; Jeon, H.; Genovesio, A.; Lee, S.; Kang, S.; Ewann, F.N.; Nam, J.Y.; Christophe, T.; Fenistein, D.P.; Jamung, H.; Jiyeon, J., Anti-infective Compounds, in, Sep 22, 2011."},{"key":"10.1016\/j.ejps.2025.107062_bib0030","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1021\/jm5002937","article-title":"Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity","volume":"57","author":"Panda","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0031","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.drudis.2016.09.014","article-title":"Structural studies of mycobacterium tuberculosis DprE1 interacting with its inhibitors","volume":"22","author":"Piton","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2025.107062_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114145","article-title":"Identification of thiophene-benzenesulfonamide derivatives for the treatment of multidrug-resistant tuberculosis","volume":"231","author":"Qin","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0033","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.1021\/acs.jmedchem.8b01356","article-title":"Identification and profiling of hydantoins\u2014A novel class of potent antimycobacterial DprE1 inhibitors","volume":"61","author":"Rogacki","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1424017","article-title":"Identification of 2-(N-aryl-1, 2, 3-triazol-4-yl) quinoline derivatives as antitubercular agents endowed with InhA inhibitory activity","volume":"12","author":"Sabt","year":"2024","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200168","article-title":"Bioevaluation of quinoline-4-carbonyl derivatives of piperazinyl-benzothiazinones as promising antimycobacterial agents","volume":"355","author":"Sahoo","year":"2022","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejps.2025.107062_bib0036","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01237-22","article-title":"Mycobacterium tuberculosis DprE1 inhibitor OPC-167832 is active against Mycobacterium abscessus In Vitro","volume":"66","author":"Sarathy","year":"2022","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.ejps.2025.107062_bib0037","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1021\/jm401382v","article-title":"Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill mycobacterium tuberculosis and are efficacious in vivo","volume":"56","author":"Shirude","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0038","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1021\/acsmedchemlett.5b00424","article-title":"Design, syntheses, and anti-TB activity of 1,3-benzothiazinone azide and click chemistry products inspired by BTZ043","volume":"7","author":"Tiwari","year":"2016","journal-title":"ACS. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2025.107062_bib0039","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1021\/ja311058q","article-title":"Thiolates chemically induce redox activation of BTZ043 and related potent nitroaromatic anti-tuberculosis agents","volume":"135","author":"Tiwari","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2025.107062_bib0040","doi-asserted-by":"crossref","first-page":"13663","DOI":"10.1021\/ja106357w","article-title":"Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-\u03b2-d-ribose 2\u2032-epimerase DprE1 of mycobacterium tuberculosis","volume":"132","author":"Trefzer","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2025.107062_bib0041","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1021\/ja211042r","article-title":"Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-\u03b2-D-ribofuranose 2\u2032-oxidase DprE1","volume":"134","author":"Trefzer","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2025.107062_bib0042","unstructured":"S.C. Vadim Makarov, 2-piperazin-1-yl-4H-1,3-benzothiazin-4-one derivatives and their use for the treatment of mammalian infections, in, 2014."},{"key":"10.1016\/j.ejps.2025.107062_bib0043","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1021\/acsinfecdis.3c00436","article-title":"Revolutionizing tuberculosis treatment: uncovering new drugs and breakthrough inhibitors to combat drug-resistant mycobacterium tuberculosis","volume":"9","author":"Verma","year":"2023","journal-title":"ACS. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107062_bib0044","first-page":"E2510","article-title":"Identification of a small molecule with activity against drug-resistant and persistent tuberculosis","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"key":"10.1016\/j.ejps.2025.107062_bib0045","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1021\/acs.jmedchem.1c00263","article-title":"Discovery of novel thiophene-arylamide derivatives as DprE1 inhibitors with potent antimycobacterial activities","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0046","unstructured":"World Health Organization. Global Tuberculosis Report, http:\/\/www.who.int\/tb\/publications\/global_report\/en\/(Accessed in 20 March 2020)."},{"key":"10.1016\/j.ejps.2025.107062_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115976","article-title":"Benzothiozinone derivatives with anti-tubercular activity-further side chain investigation","volume":"264","author":"Wu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107062_bib0048","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04721-22","article-title":"Discovery of novel reversible inhibitor of DprE1 based on benzomorpholine for the treatment of tuberculosis","volume":"11","author":"Xiang","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejps.2025.107062_bib0049","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300099","article-title":"DprE1 Inhibitors: enduring aspirations for future antituberculosis drug discovery","volume":"18","author":"Yadav","year":"2023","journal-title":"ChemMedChem."},{"key":"10.1016\/j.ejps.2025.107062_bib0050","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1021\/acsmedchemlett.3c00295","article-title":"Synthesis and structure\u2013Activity relationships of a new class of oxadiazoles targeting DprE1 as antitubercular agents","volume":"14","author":"Yadav","year":"2023","journal-title":"ACS. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2025.107062_bib0051","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1021\/acs.jmedchem.3c01703","article-title":"Discovery of N-(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) acetamide derivatives as novel noncovalent DprE1 inhibitors against mycobacterium tuberculosis","volume":"67","author":"Yang","year":"2024","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:06:31Z","timestamp":1760227591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":51,"alternative-id":["S0928098725000612"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107062","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DprE1 inhibitors: An insight into the recent developments and synthetic approaches","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107062"}}